CA2509987A1 - Diagnostic dirige sur la vimentine et methode therapeutique pour maladies neoplasiques a multiresistance aux medicaments - Google Patents

Diagnostic dirige sur la vimentine et methode therapeutique pour maladies neoplasiques a multiresistance aux medicaments Download PDF

Info

Publication number
CA2509987A1
CA2509987A1 CA002509987A CA2509987A CA2509987A1 CA 2509987 A1 CA2509987 A1 CA 2509987A1 CA 002509987 A CA002509987 A CA 002509987A CA 2509987 A CA2509987 A CA 2509987A CA 2509987 A1 CA2509987 A1 CA 2509987A1
Authority
CA
Canada
Prior art keywords
cell
vimentin
antibody
group
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002509987A
Other languages
English (en)
Inventor
Elias Georges
Lucile Serfass
Anne-Marie Bonneau
Frederic Dallaire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aurelium Biopharma Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/IB2003/006427 external-priority patent/WO2005062058A1/fr
Publication of CA2509987A1 publication Critical patent/CA2509987A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Ces méthodes permettent de détecter la multirésistance aux médicaments dans des cellules néoplasiques ou endommagées ou de détecter des cellules néoplasiques ou endommagées à multirésistance aux médicaments par détection d'une augmentation de l'expression de la protéine vimentine dans la surface de la cellule par rapport à l'expression de la protéine vimentine dans la surface d'une cellule normale ou néoplasique n'ayant pas une multirésistance aux médicaments.
CA002509987A 2002-12-13 2003-12-15 Diagnostic dirige sur la vimentine et methode therapeutique pour maladies neoplasiques a multiresistance aux medicaments Abandoned CA2509987A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43348002P 2002-12-13 2002-12-13
US60/433,480 2002-12-13
PCT/IB2003/006427 WO2005062058A1 (fr) 2002-12-13 2003-12-15 Diagnostic dirige sur la vimentine et methode therapeutique pour maladies neoplasiques a multiresistance aux medicaments

Publications (1)

Publication Number Publication Date
CA2509987A1 true CA2509987A1 (fr) 2005-07-07

Family

ID=35006468

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002509987A Abandoned CA2509987A1 (fr) 2002-12-13 2003-12-15 Diagnostic dirige sur la vimentine et methode therapeutique pour maladies neoplasiques a multiresistance aux medicaments

Country Status (2)

Country Link
AU (1) AU2003296857A1 (fr)
CA (1) CA2509987A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115069179A (zh) * 2022-07-06 2022-09-20 海南大学 一种抗菌海藻酸钙微球及其制备与应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115069179A (zh) * 2022-07-06 2022-09-20 海南大学 一种抗菌海藻酸钙微球及其制备与应用

Also Published As

Publication number Publication date
AU2003296857A1 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
US7670604B2 (en) Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
US20090004102A1 (en) HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease
JP4684940B2 (ja) 結腸直腸癌細胞に特異的に結合する組成物およびその使用方法
US7550256B2 (en) Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
US7413851B2 (en) Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
JP2006502110A (ja) 非放出Ｍｕｃ１およびＭｕｃ１６に対する抗体、およびその使用
AU2007227195A1 (en) N-cadherin and Ly6 E: targets for cancer diagnosis and therapy
US20210269549A1 (en) Anti-sas1b antibodies, associated methods of use, and compositions and methods for detecting and treating cancer
US20190310255A1 (en) Proteins
Yu et al. Mesothelin as a potential therapeutic target in human cholangiocarcinoma
JP2015172601A (ja) 細胞を検出する方法、およびこれに有用な薬剤
EP1695089A1 (fr) Diagnostic dirige sur la vimentine et methode therapeutique pour maladies neoplasiques a multiresistance aux medicaments
US20110020370A1 (en) Slc7a5 directed diagnostics and therapeutics for neoplastic disease
US7358042B2 (en) Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease
JP4532273B2 (ja) 癌に関係するタンパク質
JP2008163029A (ja) ＰＡＰ２ａに対する抗体ならびにその診断的および治療的使用
CA2509987A1 (fr) Diagnostic dirige sur la vimentine et methode therapeutique pour maladies neoplasiques a multiresistance aux medicaments
US20220411532A1 (en) Antibodies targeting an amphiregulin-derived cell surface neo-epitope
WO2023217886A1 (fr) Utilisation de la protéine rep bmmf1 en tant que marqueur diagnostique pour le cancer du pancréas et le diabète sucré de type 2
WO2023217889A1 (fr) Utilisation d'une protéine rep bmmf1 en tant que marqueur diagnostique pour le cancer du poumon
WO2006099539A1 (fr) Reg iv, cible pour le diagnostic et le traitement du cancer
Lokman Role of annexin A2 in ovarian cancer metastasis.
Borgia Chemical proteomics for the discovery of accessible markers of liver metastasis
Shively et al. The XXXIVth Meeting of the International Society for Oncodevelopmental Biology and Medicine, ISOBM 2006 September 16–20, 2006, Pasadena, Calif.

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead